Antibiotic-induced endotoxin release from bacteria and its clinical significance

Microbiology and Immunology

Volumn 41, Issue 4, 1997, Pages 285-294

  Kirikae, Teruo ^a   Nakano, Masayasu ^a   Morrison, David C ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Endotoxin; Gram negative bacteria; Lipid A associated protein; Lipopolysaccharide; LPS; Pseudomonas aeruginosa; Sepsis; Shock

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM ANTIBIOTIC; ENDOTOXIN; LIPID A; POLYMYXIN B;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIOLYSIS; ENDOTOXEMIA; GRAM NEGATIVE BACTERIUM; INFLAMMATION; LEUKOCYTE ACTIVATION; MORTALITY; SEPSIS; SEPTIC SHOCK;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0030970320     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01203.x     Document Type: Article

References (81)

1. Alem, A. 1992. A model for formulation of protein assay. Anal. Biochem. 203: 121-126.
2. Arditi, M., Ables, L., and Yogev, R. 1989. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J. Infect. Dis. 160: 1005-1011.
3. Atlas, R.M. 1993. M9 medium. In Park, L.C. (ed), Handbook of microbiological media, Vol. 529, CRC Press, Boca Raton, Florida.
4. Beaty, C.D., Franklin, T.L., Uehara, Y., and Wilson, C.B. 1994. Lipopolysaccharide induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24: 1278-1284.
5. Bone, R.C. 1993. Gram-negative sepsis: a dilemma of modern medicine. Clin. Microbiol. Rev. 6: 57-68.
6. Brade, L., Bessler, W.G., and Brade, H. 1988. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein. Infect. Immun. 56: 1382-1384.
7. Brandenburg, K., Seydel, U., Schromm, A.B., Loppnow, H., Koch, M.H.J., and Rietschel, E.T. 1996. Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharide. J. Endotoxin Res. 3: 173-178.
8. Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J.N., Halvorsen, S., and Sorensen, E. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infct. Dis. 159: 195-204.
9. Bucklin, S.E., Fujihara, Y., Leeson, M.C., and Morrison, D.C. 1994. Differential antibiotic-induced release of endotoxin from gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13 (suppl.1): 43-51.
10. Bucklin, S.E., and Morrison, D.C. 1995. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172: 1519-1527.
11. Burrell, R. 1990. Immunomodulation by bacterial endotoxin. Crit. Rev. Microbiol. 17: 189-208.
12. Cerami, A., and Beutler, B. 1988. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today 9: 28-31.
13. Devoe, I.W., and Gilchrist, J.E. 1973. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138: 1156-1167.
14. Dofferhoff, A.S.M., and Buys, J. 1995. Dose-and type-dependent antibiotic-induced endotoxin release, p. 11-19. In Faist, E. (ed), Differential release and impact of antibiotic-induced endotoxin, Raven Press, New York.
15. Dofferhoff, A.S.M., and Buys, J. 1996. The influence of antibiotic-induced filament formation on the release of endotoxin from gram-negative bacteria. J. Endotoxin Res. 3: 187-194.
16. Dofferhoff, A.S.M., Nijland, J.H., deVries-Hospers, H.G., Mulder, P.O.M., Weits, J., and Bom, V.J.J. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23: 745-754.
17. Eng, R.H.K., Smith, S.M., Fan-Havard, P., and Ogbara, T. 1993. Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 35: 185-189.
18. Eugebretsen, L.F., Kierulf, P., and Brandtzaeg, P. 1986. Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb. Res. 42: 713-716.
19. Faist, E. (ed), 1995. Differential release and impact of antibiotic-induced endotoxin, Raven Press, New York.
20. Friedland, I.R., Jafari, H., Ehrett, S., Rinderknecht, S., Paris, M., Coulthard, M., Saxen, H., Olsen, K., and McCracken, G.H., Jr. 1993. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J. Infect. Dis. 168: 657-662.
21. Fujishima, S., Sasaki, J., Shinozawa, Y., Takuma, K., Hori, S., and Aikawa, N. 1993. Interleukin 8 in ARDS. Lancet 342: 237-238.
22. Galanos, C., Freudenberg, M.A., and Reuter, W. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 75: 5939-5943.
23. Galanos, C., Lüderitz, O., and Westphal, O. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9: 245-249.
24. Galpine, J.F. 1949. Chloramphenicol in typhoid fever. B.M.J. 2: 1047-1048.
25. Hanberger, H., Nilssen, L.E., Kihlström, E., and Maller, R. 1990. Post-antibiotic effect of β-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob. Agents Chemother. 34: 102-106.
26. Henry, M.M., and Moore, J.N. 1988. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes. Circ. Shock 26: 297-309.
27. Hoekstra, D., Van Der Laan, J.W., De Leij, L., and Witholt, B. 1976. Release of outer membrane fragments from normally growing Escherichia coli. Biochim. Biophys. Acta 455: 889-899.
28. Holzheimer, R.G., Hirte, J.F., Reith, B., Engelhardt, W., Horak, K.H., Leppert, R., Aasen, A., Capel, P., Urbaschek, R., Karch, H., and Thiede, A. 1996. Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J. Endotoxin Res. 3: 261-267.
29. Homma, J.Y., Matsuura, M., and Kumazawa, Y. 1990. Structure-activity relationship of chemically synthesized nonreducing parts of lipid A analogs. Adv. Exp. Med. Biol. 256: 101-119.
30. Hopkin, B.D.A. 1978. Frapper fort ou doucement: a gram-negative dilemma. Lancet ii: 1193-1194.
31. Hopkin, B.D.A. 1985. A nasty shock from antibiotics. Lancet ii: 594.
32. Hopkin, B.D.A. 1977. Too-rapid destruction of gram-negative organisms. Lancet ii: 603-604.
33. Hsueh, W., Gonzalez-Crussi, F., and Arroyave, J.L. 1987. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASAB J. 1: 403-405.
34. Hurley, J.C. 1995. Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Rev. 8: 268-292.
35. Hurley, J.C., Louis, W.J., Tosolini, F.A., and Carlin, J.B. 1991. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob. Agents Chemother. 35: 2388-2394.
36. Jackson, J.J., and Kropp, H. 1996. Differences in mode of action of β-lactum antibiotics influence morphorogy, LPS release and in vivo antibiotic efficacy. J. Endotoxin Res. 3: 201-218.
37. Johns, M.A., Sipe, J.D., Melton, L.B., Strom, T.B., and McCabe, W.R. 1988. Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect. Immun. 56: 1593-1601.
38. Jorgensen, J.H., and Smith, R.F. 1974. Measurement of bound and free endotoxin by the Limulus assay. Proc. Soc. Exp. Biol. Med. 146: 1024-1031.
39. Kirikae, F., Kirikae, T., Qureshi, N., Takayama, K., Morrison, D.C., and Nakano, M. 1995. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect. Immun. 63: 486-497.
40. Kirikae, T., Schade, F.U., Kirikae, F., Rietschel, E.T., and Morrison, D.C. 1993. Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide. Influence of serum and lipopolysaccharide chain length on macrophage activation. J. Immunol. 151: 2742-2752.
41. Kotani, S., and Takada, H. 1990. Structural requirements of lipid A for endotoxicity and biological activities: an overview. Adv. Exp. Med. Biol. 256: 13-43.
42. Kreger, B.E., Craven, D.E., and McCabe, W.R. 1980. Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients. Am. J. Med. 68: 344-355.
43. Lamp, K.C., Rybak, M.J., McGrath, B.J., and Summers, K.K. 1996. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40: 247-252.
44. Leeson, M.C., Fujihara, Y., and Morrison, D.C. 1994. Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect. Immun. 62: 4975-4980.
45. MacMicking, J.D., Nathan, C., Hom, G., Chartrain, N., Flecher, D.S., Trumbauer, M., Stevens, K., Xie, Q., Sokol, K., Hitchinson, N., Chen, H., and Mudgett, J.S. 1995. Altered response to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650.
46. Manthey, C.L., and Vogel, S.N. 1994. Elimination of trace endotoxin protein from rough chemotype LPS. J. Endotoxin Res. 1: 84-91.
47. Marchant, A., Deviere, J., Byl, B., de-Groote, D., Vincent, J.L., and Goldman, M. 1994. Interleukin-10 production during septicemia. Lancet 343: 707-708.
48. Mayer, H., Campos-Portuguez, S.A., Busch, M., Urbanik-Sypniewska, T., and Bhat, U.R. 1990. Lipid A variants - or, how constant are the constant regions in lipopolysaccharides? p. 111-120. In Nowotny, A., Spitzer, J.J., and Jiegler, E.J. (eds), Cellular and molecular aspects of endotoxin reactions, Elsevier, Amsterdam.
49. McCartney, A.C., Piotrowicz, B.I., Edlin, S.E., and Ledingham, I.M. 1987. Evaluation of the chromogenic Limulus lysate assay in septic shock, p. 459-474. In Watson, S.H., Levin, J., and Novitsky, T.J. (eds), Detection of bacterial endotoxins with the Limulus amebocyte lysate test, Alan R. Liss, New York.
50. Mock, C.N., Jurkovich, G.J., Dries, D.J., and Maier, R.V. 1996. The clinical significance of endotoxin released by antibiotics: what is the evidence? J. Endotoxin Res. 3: 253-259.
51. Mock, C.N., Jurkovich, G.J., Dries, D.J., and Maier, R.V. 1995. Clinical significance of antibiotic endotoxin releasing properties in trauma patients. Arch. Surg. 130: 1234-1241.
52. Morrison, D.C., Betz, S.J., and Jacobs, D.M. 1976. Isolation of a lipid A bound polypeptide responsible for 'LPS-initiated' mitogenesis of C3H/HeJ spleen cells. J. Exp. Med. 144: 840-846.
53. Morrison, D.C., and Bucklin, S.E. 1995. Endotoxemia, bacteremia, and the pathogenesis of gram-negative sepsis. Faist, E. (Coordinating ed), Raven Press, New York.
54. Morrison, D.C., Bucklin, S.E., Leeson, M.C., and Norimatsu, M. 1996. Contribution of soluble endotoxin released from Gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice. J. Endotoxin Res. 3: 237-243.
55. Morrison, D.C., Danner, R.L., Dinarello, C.A., Munford, R.S., Natanson, C., Pollack, M., Spitzer, J.J., Ulevitch, R.J., Vogel, S.N., and McSweegan, E. 1994. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J. Endotoxin Res. 1: 71-83.
56. Mustafa, M.M., Mertosola, J., Ramilo, O., Saez-Llorens, X., Risser, R.C., and McCracken, G.H. 1989. Increased endotoxin and interleukin-1β concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J. Infect. Dis. 160: 891-895.
57. Mustafa, M.M., Ramilo, O., Mertsola, J., Risser, R.C., Beutler, B., Hansen, E.J., and McCracken, G.H.J. 1989. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J. Infect. Dis. 160: 818-825.
58. Nakano, M., Asou, H., and Yamamoto, I. 1975. Stimulation of phagocytic activity in the reticuloendothelial systems of mice by lipid A complexed with homologous or heterologous proteins. Infect. Immun. 11: 592-594.
59. Nakano, M., and Kirikae, T. 1996. Biological characterization of Pseudomonas aeruginosa endotoxin released by antibiotic treatment in vitro. J. Endotoxin Res. 3: 195-200.
60. Neu, H.C. 1985. Relation of structural properties of β-lactam antibiotics to antibacterial activity. Am. J. Med. 79(2A): 2-13.
61. Obayashi, T., Tamura, H., Tanaka, S., Ohki, M., Takahashi, S., and Kawai, T. 1986. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect. Immun. 53: 294-297.
62. Opal, S.M., Horn, D.L., Palardy, J.E., Parejo, N., Jhung, J., Bhattacharjee, A., and Young, L.D. 1996, The in vivo significance of antibiotic-induced endotoxin release in experimental gram-negative sepsis. J. Endotoxin Res. 3: 245-252.
63. Prins, J.M. 1996. Antibiotic induced release of endotoxin -clinical data and human studies. J. Endotoxin Res. 3: 269-273.
64. Prins, J.M., van Agtmael, M.A., Kuijper, E.J., Van Deventer, S.J.H., and Speelman, P. 1995. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172: 886-891.
65. Prins, J.M., van Deventer, S.T.H., Kuijper, E.J., and Speelman, P. 1994. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob. Agents Chemother. 38: 1211-1218.
66. Rietschel, E.T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A.J., Mattem, T., Heine, H., Schletter, J., Loppnow, H., Schönbeck, U., Flad, H.-D., Hauschildt, S., Schade, U.F., Di Padova, F., Kusumoto, S., and Scumann, R.R. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216: 39-81.
67. Schumann, R.R., Leong, S.R., Flaggs, G.W., Gray, P.W., Wright, S.D., Mathison, J.C., Tobias, P.S., and Ulevitch, R.J. 1990. Structure and function of lipopolysaccharide binding protein. Science. 249: 1429-1431.
68. Shenep, J.L., Barton, R.P., and Morgan, K.A. 1985. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative sepsis. J. Infect. Dis. 151: 1012-1018.
69. Shenep, J.L., Flynn, P.M., Barrett, F.F., Stidham, G.L., and Westenkirchner, D.F. 1988. Serial quantitation of endotoxemia and bacteremia during the therapy for Gram-negative bacterial sepsis. J. Infect. Dis. 157: 565-568.
70. Shinomiya, H., Hirata, H., and Nakano, M. 1991. Purification and characterization of the 65-kDa protein phosphorylated in murine macrophages by stimulation with bacterial lipopolysaccharide. J. Immunol. 146: 3617-3625.
71. Spink, W.W., Hall, W.H., Shaffer, J.M., and Braude, A.I. 1948. Human brucellosis: its specific treatment with a combination of streptomycin and sulfadiazine. J.A.M.A. 136: 382.
72. Suda, Y., Kirikae, T., Shiyama, T., Yasukochi, T., Kirikae, F., Nakano, M., Rietschel, E.T., and Kusumoto, S. 1995. Macrophage activation in response to S-form lipopolysaccharides (LPS) separated by centrifugal partition chromatography from wild-type LPS: effects of the O-polysaccharide portion of LPS. Biochem. Biophys. Res. Commun. 210: 678-686.
73. Synder, F. 1990. Platelet-activating factor and related lipids as potent biologically active cellular mediators. Am. J. Physiol. 259: C697-708.
74. Tauber, M.G., Shibl, A.M., Hackbarth, C.L., Larrick, J.W., and Sande, M.A. 1987. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J. Infect. Dis. 156: 456-462.
75. Thiemermann, C., and Vane, J. 1992. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182: 591-595.
76. Tracey, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Kuo, G.C., Lowry, S.F., and Cerami, A. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330: 662-664.
77. Tuomanen, E., Gilbert, K., and Tomasz, A. 1986. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob. Agents Chemother. 30: 659-663.
78. Wei, X., Charles, I.G., Smith, A., Ure, J., Feng, G., Huang, F., Xu, D., Muller, W., Moncada, S., and Liew, F.Y. 1995. Altered responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411.
79. Weinstein, S., Sanghera, J.S., Lemke, K., DeFranco, A.L., and Pelech, S.L. 1992. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267: 14955-14962.
80. Westphal, O., Lüderitz, O., and Bister, F. 1952. Über die Extraktion von Bakterien mit Phenol/Wasser. Ztsch. Naturforsch. 7b: 148-155.
81. Wright, S.D., Ramos, R.A., Patel, M., and Miller, D.S. 1992. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD 14 on phagocytes. J. Exp. Med. 176: 719-727.